Form 4 for IGC IGC Pharma, Inc.
Accepted 2023-06-28 00:00:00 ET · period of report 2023-03-31 · accession 0001185185-23-000670 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-06-28 | 2023-03-31 | IGC | Moran James P | Dir | M - OptEx | $0.00 | +83.3K | 133.3K | +167% | $0 |
| DM | 2023-06-28 | 2022-05-25+ | IGC | Moran James P | Dir | A - Grant | $0.00 | +540.0K | 240.0K | New | $0 |
| DM | 2023-06-28 | 2023-03-31 | IGC | Moran James P | Dir | M - OptEx | $0.00 | -83.3K | 50.0K | -63% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-31 | M | A | 50,000 | $0.00 | 100,000 | D | — | — | (F1) Represents 150,000 restricted shares of IGC common stock subject to vesting equally over three years starting on January 18, 2022, and then on March 31, 2023, and 2024, as per the RSU Agreement with Director Moran. |
| 2 | Common | Common Stock | 2023-03-31 | M | A | 33,334 | $0.00 | 133,334 | D | — | — | (F2) On May 25, 2022, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 31, 2023. |
| 3 | Derivative | Restricted Stock Units | 2022-05-25 | A | A | 100,000 | $0.00 | 100,000 | D | — · — to — | 100,000 Common Stock | (F2) On May 25, 2022, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 31, 2023. (F5) Each restricted stock unit represents a right to receive one share of IGC common stock. |
| 4 | Derivative | Restricted Stock Units | 2023-03-31 | M | D | 33,334 | $0.00 | 66,666 | D | — · — to — | 33,334 Common Stock | (F2) On May 25, 2022, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 31, 2023. (F5) Each restricted stock unit represents a right to receive one share of IGC common stock. |
| 5 | Derivative | Restricted Stock Units | 2023-06-20 | A | A | 200,000 | $0.00 | 200,000 | D | — · — to 2033-03-31 | 200,000 Common Stock | (F4) On June 20, 2023, the Reporting Person was granted RSUs subject to vesting according to specific milestones set by the Company's Board of Directors. The RSUs vest when milestones are achieved. (F5) Each restricted stock unit represents a right to receive one share of IGC common stock. |
| 6 | Derivative | Restricted Stock Units | 2023-06-20 | A | A | 240,000 | $0.00 | 240,000 | D | — · — to — | 240,000 Common Stock | (F3) On June 20, 2023, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 31, 2024. (F5) Each restricted stock unit represents a right to receive one share of IGC common stock. |
| 7 | Derivative | Restricted Stock Units | 2023-03-31 | M | D | 50,000 | $0.00 | 50,000 | D | — · — to — | 50,000 Common Stock | (F1) Represents 150,000 restricted shares of IGC common stock subject to vesting equally over three years starting on January 18, 2022, and then on March 31, 2023, and 2024, as per the RSU Agreement with Director Moran. |